Skip to main content

Lymphadenopathy clinical trials at UCSF
1 in progress, 1 open to new patients

  • Retroperitoneal Lymph Node Dissection in Treating Patients With Testicular Seminoma

    open to eligible males ages 16 years and up

    This phase II trial studies how well retroperitoneal lymph node dissection (RPLND) works in treating patients with stage I-IIa testicular seminoma. The retroperitoneum is the space in the body behind the intestines that is typically the first place that seminoma spreads. RPLND is a surgery that removes lymph nodes in this area to treat testicular seminoma and may experience fewer long-term toxicities, such as a second cancer, cardiovascular disease, metabolic syndrome (pre-diabetes), or lung disease.

    San Francisco, California and other locations